154 related articles for article (PubMed ID: 17094435)
41. A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment.
Yang M; Reynoso J; Bouvet M; Hoffman RM
J Cell Biochem; 2009 Feb; 106(2):279-84. PubMed ID: 19097136
[TBL] [Abstract][Full Text] [Related]
42. [Establishment and characterization of dual-color fluorescence nude mouse models of glioma].
Zhang J; Lu Z; Fei X; Dai X; Wu J; Wan Y; Wang Z; Wang A; Dong J; Lan Q; Huang Q
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):97-102. PubMed ID: 24796456
[TBL] [Abstract][Full Text] [Related]
43. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
44. Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis.
Hoffman RM
Cancer Metastasis Rev; 1998-1999; 17(3):271-7. PubMed ID: 10352880
[TBL] [Abstract][Full Text] [Related]
45. Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis.
Zhang Y; Miwa S; Zhang N; Hoffman RM; Zhao M
Oncotarget; 2015 Feb; 6(5):2615-22. PubMed ID: 25575815
[TBL] [Abstract][Full Text] [Related]
46. Imaging the interaction of α
Tome Y; Kiyuna T; Uehara F; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM
J Cell Biochem; 2019 Jan; 120(1):283-289. PubMed ID: 30145815
[TBL] [Abstract][Full Text] [Related]
47. Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.
Murakami T; Hiroshima Y; Miyake K; Hwang HK; Kiyuna T; DeLong JC; Lwin TM; Matsuyama R; Mori R; Kumamoto T; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
Cell Cycle; 2017 May; 16(10):1008-1014. PubMed ID: 28441080
[TBL] [Abstract][Full Text] [Related]
48. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
[TBL] [Abstract][Full Text] [Related]
49. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells.
Yang M; Li L; Jiang P; Moossa AR; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14259-62. PubMed ID: 14614130
[TBL] [Abstract][Full Text] [Related]
50. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
Bouvet M; Hoffman RM
Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
[TBL] [Abstract][Full Text] [Related]
51. In vivo cell biology of cancer cells visualized with fluorescent proteins.
Hoffman RM
Curr Top Dev Biol; 2005; 70():121-44. PubMed ID: 16338340
[TBL] [Abstract][Full Text] [Related]
52. GFP-expressing vascularization of Gelfoam as a rapid in vivo assay of angiogenesis stimulators and inhibitors.
Amoh Y; Li L; Katsuoka K; Bouvet M; Hoffman RM
Biotechniques; 2007 Mar; 42(3):294, 296, 298. PubMed ID: 17390535
[No Abstract] [Full Text] [Related]
53. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy.
Raykov Z; Grekova SP; Bour G; Lehn JM; Giese NA; Nicolau C; Aprahamian M
Int J Cancer; 2014 Jun; 134(11):2572-82. PubMed ID: 24214898
[TBL] [Abstract][Full Text] [Related]
54. "Color Timer" mice: visualization of neuronal differentiation with fluorescent proteins.
Kanki H; Shimabukuro MK; Miyawaki A; Okano H
Mol Brain; 2010 Feb; 3():5. PubMed ID: 20205849
[TBL] [Abstract][Full Text] [Related]
55. Color-Coded Imaging of Breast Cancer Metastatic Niche Formation in Nude Mice.
Suetsugu A; Momiyama M; Hiroshima Y; Shimizu M; Saji S; Moriwaki H; Bouvet M; Hoffman RM
J Cell Biochem; 2015 Dec; 116(12):2730-4. PubMed ID: 25981355
[TBL] [Abstract][Full Text] [Related]
56. [Tumor angiogenesis promoted by fusion of glioma stem/progenitor cells with bone marrow mesenchymal stem cells].
Zhao D; Dai X; Sun C; Chen J; Rong X; Wang H; Wang Q; Rui Q; Wang A; Wang Z; Dong J; Lan Q; Huang Q
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):336-41. PubMed ID: 26463022
[TBL] [Abstract][Full Text] [Related]
57. Color-coded Imaging Distinguishes Cancer Cells, Stromal Cells, and Recombinant Cancer-stromal Cells in the Tumor Microenvironment During Metastasis.
Nakamura M; Suetsugu A; Hasegawa K; Satake T; Kunisada T; Shimizu M; Saji S; Moriwaki H; Hoffman RM
Anticancer Res; 2018 Aug; 38(8):4417-4423. PubMed ID: 30061205
[TBL] [Abstract][Full Text] [Related]
58. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
[TBL] [Abstract][Full Text] [Related]
59. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
[TBL] [Abstract][Full Text] [Related]
60. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
Hoffman RM; Bouvet M
Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
